Two Sigma Investments’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $57.3K | Sell |
95,417
-75,127
| -44% | -$45.1K | ﹤0.01% | 3008 |
|
|
2025
Q1 | $46K | Buy |
170,544
+42,965
| +34% | +$11.6K | ﹤0.01% | 2990 |
|
|
2024
Q4 | $66.3K | Sell |
127,579
-63,736
| -33% | -$33.1K | ﹤0.01% | 2952 |
|
|
2024
Q3 | $620K | Sell |
191,315
-11,946
| -6% | -$38.7K | ﹤0.01% | 2301 |
|
|
2024
Q2 | $610K | Sell |
203,261
-23,778
| -10% | -$71.3K | ﹤0.01% | 2198 |
|
|
2024
Q1 | $1.06M | Sell |
227,039
-75,705
| -25% | -$352K | ﹤0.01% | 1867 |
|
|
2023
Q4 | $1.25M | Buy |
302,744
+105,547
| +54% | +$437K | ﹤0.01% | 1869 |
|
|
2023
Q3 | $592K | Sell |
197,197
-107,689
| -35% | -$323K | ﹤0.01% | 2136 |
|
|
2023
Q2 | $750K | Sell |
304,886
-99,389
| -25% | -$244K | ﹤0.01% | 2044 |
|
|
2023
Q1 | $914K | Sell |
404,275
-122,887
| -23% | -$278K | ﹤0.01% | 1851 |
|
|
2022
Q4 | $1.84M | Buy |
527,162
+475,274
| +916% | +$1.66M | 0.01% | 1308 |
|
|
2022
Q3 | $1.92M | Buy |
51,888
+40,537
| +357% | +$1.5M | 0.01% | 1133 |
|
|
2022
Q2 | $216K | Buy |
11,351
+851
| +8% | +$16.2K | ﹤0.01% | 2068 |
|
|
2022
Q1 | $283K | Buy |
+10,500
| New | +$283K | ﹤0.01% | 2192 |
|